United States · 
What does Yasuda Enterprise Development invest in?
Yasuda Enterprise Development invests most often at Series B and Series C (67% of the rounds on record), in sectors such as Hospital and Medical.
Yasuda Enterprise Development highlights
- 01
12 rounds on record
- 02
Mostly Series B and Series C: 67% of its rounds
- 03
2 exits from the portfolio
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- HospitalMedical
- Based in
- United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first12 appearances
- 2008
1 round
- Sept
- 2006
2 rounds
- Dec
- Oct
- 2005
1 round
- Jan
- 2004
2 rounds
- Mar
- Jan
- 2003
3 rounds
- Dec
- Aug
- Jan
- 2002
2 rounds
- Dec
- Jan
- 2001
1 round
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
Enanta PharmaceuticalsListed$56MMar 2013
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.